We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Raman Technique Visualizes Details Almost to a Trillionth of a Meter

By MedImaging staff writers
Posted on 05 May 2008
A team of researchers has developed a new type of imaging system that can illuminate tumors in living subjects--obtaining images with a precision of nearly one-trillionth of a meter. More...


This technique, called Raman spectroscopy, expands the existing range of tools for the field of molecular imaging, according to team leader Sanjiv Sam Gambhir, M.D., Ph.D., professor of radiology at Stanford University School of Medicine (Stanford, CA, USA). He is the senior author of a study describing the application that was published in the March 31, 2008, advance online issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS).

"This is an entirely new way of imaging living subjects, not based on anything previously used,” said Dr. Gambhir, who directs the Molecular Imaging Program at Stanford. He reported that signals from Raman spectroscopy are stronger and longer lived than other available techniques, and the type of particles used in this method can transmit information about multiple types of molecular targets simultaneously. "Usually we can measure one or two things at a time,” he said. "With this, we can now likely see 10, 20, 30 things at once.

Dr. Gambhir reported that he believes this is the first time Raman spectroscopy has been used to image deep within the body, using tiny nanoparticles injected into the body to serve as beacons. When laser light is beamed from a source outside the body, these specialized particles emit signals that can be measured and translated into a visible indicator of their location in the body.

Postdoctoral scholars Shay Keren, Ph.D., and Cristina Zavaleta, Ph.D., co-first authors of the study, found a way to make Raman spectroscopy a medical application. To accomplish this, they used two types of engineered Raman nanoparticles: gold nanoparticles and single-wall carbon nanotubes. First, they injected mice with the some of the nanoparticles. To see the nanoparticles, they used a special microscope that the group had adapted to view anesthetized mice exposed to laser light. The researchers could see that the nanoparticles migrated to the liver, where they were processed for excretion.

To be able to detect molecular events, according to Dr. Zavaleta, they labeled separate batches of spectrally unique Raman nanoparticles with different "tags” (peptides or antibodies) and then injected them into the body simultaneously to see where they went. For example, if each type of particle migrated to a different tumor site, the newly developed Raman microscope would enable the researchers to separate the signals from each batch of particles.

As part of this proof-of-principle work, Dr. Gambhir's team tagged the gold nanoparticles with different bits of proteins that homed in on different tumor molecules. "We could attach pretty much anything,” said Dr. Gambhir. The Raman effect also lasts indefinitely, so the particles do not lose effectiveness as indicators as long as they stay in the body.

Using a microscope they modified to detect Raman nanoparticles, the researchers were able to visualize targets on a scale 1,000 times smaller than what is now obtainable by the most precise fluorescence imaging using quantum dots. When modified for human use, they researchers reported, the technique has the potential to be useful during surgery, for example, in the removal of cancerous tissue. The extreme sensitivity of the imager could enable detection of even the smalltest malignant tissues.

A clinical trial is planned to test the gold nanoparticles in humans for possible use in conjunction with a colonoscopy to indicate early-stage colorectal cancer.


Related Links:
Stanford University School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.